It is integrated research into the pathogenesis, diagnosis, and treatment of cardiovascular disease. The Strategic Plan’s clinical and translational research goals emphasize the transmission of knowledge between basic and clinical research so that findings in one arena rapidly inform and stimulate research in the cardiovascular field.
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Clinical pharmacology of sotatercept - The novel quality advancement in biological therapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through bio design-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico